BioWorld MedTech

July 30, 2015

View Archived Issues

Drugs, Devices and More: The Foresite saga: Third capital fund gets $450M to carry strategy onward

Spectranetics enrolls study: Insider stock buys, enrollment give Spectranetics shares a modest bounce

Inside the Beltway: App association chief says fix health IT payment or face economic disaster

Financings: Bigfoot Biomedical raises $3.8 million

Agreements/contracts: Biodesix partners with Biognosys for HRM tech

Patent Watch: Luxcath awarded U.S. patent for tech visualizing ablated tissue

Products

Briefly noted

MDD's Orthopedics Extra

Edwards beats quarterly estimates: TAVR market growth propels Edwards'Q2 sales above analyst expectations

A booming transcatheter aortic valve replacement/implant market knocked quarterly sales out of the park for Edwards Lifesciences (NYSE: EW) (Irvine, Calif.). Read More

Latin America: A battle lost, but war continues in PIP case against T V Rheinland

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...